Takeda’s Dengue Vaccine Authorized For Use In EU
December 09, 2022
Reuters (12/8, Grover) reports, “A dengue vaccine developed by Japanese drugmaker Takeda Pharmaceutical Co was authorized for use in the European Union on Thursday, making it the second approved inoculation against the mosquito-borne disease that causes m...